| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Connexins | 148 | 2026 | 208 | 16.740 |
Why?
|
| Gap Junctions | 94 | 2024 | 146 | 8.100 |
Why?
|
| Cataract | 32 | 2023 | 87 | 7.720 |
Why?
|
| Lens, Crystalline | 29 | 2023 | 67 | 7.230 |
Why?
|
| Connexin 43 | 58 | 2026 | 95 | 5.940 |
Why?
|
| Eye Proteins | 26 | 2022 | 131 | 3.140 |
Why?
|
| Anemia, Sickle Cell | 5 | 2025 | 158 | 1.840 |
Why?
|
| Acute Chest Syndrome | 4 | 2025 | 22 | 1.600 |
Why?
|
| Endothelial Cells | 6 | 2021 | 500 | 1.370 |
Why?
|
| Extracellular Vesicles | 3 | 2021 | 57 | 1.350 |
Why?
|
| Mutation | 24 | 2024 | 4392 | 1.340 |
Why?
|
| Cell Communication | 33 | 2024 | 222 | 1.320 |
Why?
|
| Adherens Junctions | 2 | 2021 | 35 | 1.280 |
Why?
|
| Animals | 153 | 2024 | 28894 | 1.270 |
Why?
|
| Myocardium | 26 | 2008 | 578 | 1.190 |
Why?
|
| Heart Atria | 8 | 2017 | 255 | 1.050 |
Why?
|
| Intercellular Junctions | 21 | 2020 | 69 | 1.030 |
Why?
|
| HeLa Cells | 30 | 2022 | 523 | 1.030 |
Why?
|
| Membrane Proteins | 34 | 2007 | 1285 | 1.000 |
Why?
|
| Immunoblotting | 25 | 2018 | 274 | 0.880 |
Why?
|
| Mice | 53 | 2023 | 12698 | 0.810 |
Why?
|
| Ion Channels | 21 | 2012 | 259 | 0.760 |
Why?
|
| Gene Expression Regulation | 17 | 2018 | 2023 | 0.720 |
Why?
|
| Cells, Cultured | 33 | 2020 | 2855 | 0.710 |
Why?
|
| Point Mutation | 3 | 2013 | 237 | 0.710 |
Why?
|
| Transfection | 22 | 2018 | 883 | 0.680 |
Why?
|
| Mutation, Missense | 5 | 2021 | 302 | 0.670 |
Why?
|
| Endothelium, Vascular | 7 | 2020 | 440 | 0.660 |
Why?
|
| Calcium | 7 | 2023 | 1196 | 0.650 |
Why?
|
| Molecular Sequence Data | 34 | 2011 | 2896 | 0.650 |
Why?
|
| Glutathione | 1 | 2020 | 108 | 0.640 |
Why?
|
| Rats | 51 | 2014 | 4071 | 0.630 |
Why?
|
| Sequestosome-1 Protein | 1 | 2020 | 23 | 0.630 |
Why?
|
| Phenylbutyrates | 2 | 2018 | 11 | 0.600 |
Why?
|
| Epithelial Cells | 5 | 2022 | 709 | 0.590 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 412 | 0.580 |
Why?
|
| Amino Acid Sequence | 26 | 2017 | 2005 | 0.560 |
Why?
|
| Aquaporins | 3 | 2013 | 14 | 0.560 |
Why?
|
| Amino Acid Substitution | 6 | 2016 | 334 | 0.550 |
Why?
|
| Electrophysiology | 20 | 2017 | 384 | 0.540 |
Why?
|
| Cadherins | 4 | 2021 | 184 | 0.510 |
Why?
|
| Lysosomes | 5 | 2022 | 126 | 0.500 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2019 | 98 | 0.500 |
Why?
|
| Ion Channel Gating | 10 | 2014 | 318 | 0.490 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 87 | 0.480 |
Why?
|
| Humans | 89 | 2026 | 98080 | 0.480 |
Why?
|
| Crystallins | 4 | 2023 | 5 | 0.470 |
Why?
|
| Cell Line | 20 | 2014 | 2483 | 0.460 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 2572 | 0.460 |
Why?
|
| Heart Conduction System | 10 | 2012 | 143 | 0.460 |
Why?
|
| DNA | 11 | 2014 | 1274 | 0.460 |
Why?
|
| Mice, Mutant Strains | 5 | 2020 | 217 | 0.440 |
Why?
|
| Myocytes, Cardiac | 4 | 2020 | 328 | 0.440 |
Why?
|
| Atrial Fibrillation | 4 | 2014 | 461 | 0.440 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 446 | 0.420 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2024 | 273 | 0.420 |
Why?
|
| Patch-Clamp Techniques | 14 | 2014 | 381 | 0.420 |
Why?
|
| Cloning, Molecular | 17 | 2007 | 581 | 0.390 |
Why?
|
| Microscopy, Fluorescence | 12 | 2018 | 435 | 0.380 |
Why?
|
| Fluorescent Antibody Technique | 26 | 2012 | 310 | 0.380 |
Why?
|
| RNA, Messenger | 27 | 2017 | 2063 | 0.370 |
Why?
|
| Base Sequence | 21 | 2011 | 2222 | 0.360 |
Why?
|
| Mice, Knockout | 9 | 2020 | 2207 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 977 | 0.360 |
Why?
|
| Electric Conductivity | 20 | 2005 | 142 | 0.350 |
Why?
|
| Hypoxia | 1 | 2017 | 699 | 0.340 |
Why?
|
| Apoptosis | 3 | 2009 | 1752 | 0.340 |
Why?
|
| Cell Differentiation | 5 | 2014 | 1646 | 0.340 |
Why?
|
| Kidney | 4 | 2008 | 1123 | 0.330 |
Why?
|
| Oocytes | 13 | 2012 | 213 | 0.320 |
Why?
|
| Connexin 26 | 8 | 2012 | 18 | 0.320 |
Why?
|
| Polymorphism, Genetic | 3 | 2014 | 831 | 0.320 |
Why?
|
| Isoquinolines | 12 | 2012 | 58 | 0.300 |
Why?
|
| Immunohistochemistry | 20 | 2016 | 1815 | 0.290 |
Why?
|
| Multienzyme Complexes | 3 | 2000 | 54 | 0.290 |
Why?
|
| Chick Embryo | 16 | 2004 | 176 | 0.280 |
Why?
|
| Cysteine Endopeptidases | 3 | 2000 | 89 | 0.280 |
Why?
|
| Microscopy, Electron | 12 | 2008 | 435 | 0.280 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 2373 | 0.270 |
Why?
|
| Xenopus | 8 | 2021 | 120 | 0.270 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2026 | 112 | 0.260 |
Why?
|
| Chickens | 15 | 2001 | 195 | 0.250 |
Why?
|
| Models, Biological | 11 | 2009 | 1807 | 0.250 |
Why?
|
| Adenoviridae | 2 | 2007 | 340 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2007 | 668 | 0.250 |
Why?
|
| Cytoplasm | 5 | 2011 | 276 | 0.240 |
Why?
|
| Mice, Inbred C3H | 3 | 2018 | 370 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 2 | 2001 | 356 | 0.240 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 301 | 0.240 |
Why?
|
| Alleles | 1 | 2009 | 1159 | 0.240 |
Why?
|
| Antigens, CD | 2 | 2020 | 484 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 3598 | 0.230 |
Why?
|
| Male | 24 | 2025 | 47076 | 0.230 |
Why?
|
| Oxidative Stress | 1 | 2009 | 489 | 0.230 |
Why?
|
| Homozygote | 4 | 2020 | 212 | 0.230 |
Why?
|
| Oligopeptides | 5 | 2014 | 207 | 0.230 |
Why?
|
| Phosphorylation | 10 | 2020 | 1145 | 0.230 |
Why?
|
| Membrane Potentials | 13 | 2018 | 406 | 0.230 |
Why?
|
| Child, Preschool | 6 | 2020 | 4001 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 10 | 2012 | 895 | 0.220 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2020 | 70 | 0.220 |
Why?
|
| Somites | 1 | 2004 | 19 | 0.220 |
Why?
|
| Histones | 2 | 2020 | 370 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2014 | 237 | 0.220 |
Why?
|
| Cell Nucleus | 2 | 2020 | 615 | 0.210 |
Why?
|
| Action Potentials | 5 | 2014 | 611 | 0.210 |
Why?
|
| Exons | 3 | 2001 | 451 | 0.210 |
Why?
|
| Embryonic Development | 2 | 2004 | 85 | 0.210 |
Why?
|
| Sequence Deletion | 3 | 2016 | 207 | 0.210 |
Why?
|
| Gene Transfer Techniques | 2 | 2004 | 155 | 0.210 |
Why?
|
| Paracrine Communication | 1 | 2004 | 32 | 0.210 |
Why?
|
| Cell Membrane | 8 | 2012 | 673 | 0.210 |
Why?
|
| Proteasome Inhibitors | 2 | 2014 | 52 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 6 | 2012 | 731 | 0.200 |
Why?
|
| Minerals | 1 | 2023 | 21 | 0.200 |
Why?
|
| Gene Expression | 11 | 2014 | 1320 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 707 | 0.190 |
Why?
|
| Glioblastoma | 1 | 2026 | 299 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2017 | 403 | 0.190 |
Why?
|
| alpha-L-Fucosidase | 2 | 1995 | 2 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 17 | 2006 | 1028 | 0.190 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2009 | 69 | 0.190 |
Why?
|
| Protein Transport | 6 | 2012 | 448 | 0.190 |
Why?
|
| Female | 26 | 2025 | 51536 | 0.190 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2000 | 234 | 0.190 |
Why?
|
| Body Patterning | 1 | 2004 | 219 | 0.190 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2000 | 122 | 0.190 |
Why?
|
| Protein Kinase C | 2 | 2002 | 267 | 0.190 |
Why?
|
| Blotting, Southern | 5 | 2014 | 107 | 0.180 |
Why?
|
| Fluorescent Dyes | 11 | 2007 | 257 | 0.180 |
Why?
|
| Gene Deletion | 2 | 2020 | 353 | 0.180 |
Why?
|
| Animals, Newborn | 7 | 2013 | 524 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2024 | 325 | 0.170 |
Why?
|
| Recombinant Proteins | 8 | 2007 | 993 | 0.170 |
Why?
|
| Amino Acids | 3 | 2012 | 246 | 0.170 |
Why?
|
| Kinetics | 13 | 2007 | 1476 | 0.170 |
Why?
|
| Mutant Proteins | 2 | 2013 | 98 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 200 | 0.170 |
Why?
|
| Heart Ventricles | 10 | 2000 | 664 | 0.170 |
Why?
|
| Biological Transport | 4 | 2013 | 401 | 0.170 |
Why?
|
| Biotin | 3 | 2013 | 45 | 0.170 |
Why?
|
| Blotting, Northern | 15 | 1995 | 239 | 0.170 |
Why?
|
| Atrioventricular Node | 2 | 2020 | 37 | 0.160 |
Why?
|
| Endothelium | 1 | 2020 | 63 | 0.160 |
Why?
|
| Cell Line, Tumor | 4 | 2026 | 2888 | 0.160 |
Why?
|
| Heme | 1 | 2020 | 66 | 0.160 |
Why?
|
| Protein Structure, Secondary | 3 | 2011 | 340 | 0.160 |
Why?
|
| Autophagy-Related Proteins | 1 | 2020 | 23 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2019 | 56 | 0.160 |
Why?
|
| Child | 4 | 2020 | 7681 | 0.160 |
Why?
|
| eIF-2 Kinase | 2 | 2019 | 52 | 0.160 |
Why?
|
| Protease Inhibitors | 5 | 2004 | 71 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2025 | 604 | 0.150 |
Why?
|
| Epitopes | 2 | 2000 | 258 | 0.150 |
Why?
|
| Microcirculation | 1 | 2020 | 101 | 0.150 |
Why?
|
| Protein Synthesis Inhibitors | 4 | 2014 | 35 | 0.150 |
Why?
|
| Transcription Factor CHOP | 1 | 2019 | 16 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2026 | 839 | 0.150 |
Why?
|
| Cattle | 5 | 2001 | 397 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 312 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 419 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2011 | 557 | 0.150 |
Why?
|
| Half-Life | 4 | 2004 | 89 | 0.140 |
Why?
|
| Cycloheximide | 3 | 2014 | 54 | 0.140 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 169 | 0.140 |
Why?
|
| Adolescent | 4 | 2020 | 10080 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 291 | 0.140 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 102 | 0.140 |
Why?
|
| Xenopus laevis | 8 | 2014 | 140 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2020 | 218 | 0.130 |
Why?
|
| Spermine | 3 | 2009 | 25 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 419 | 0.130 |
Why?
|
| Lectins | 4 | 1982 | 82 | 0.130 |
Why?
|
| Hot Temperature | 1 | 1998 | 228 | 0.130 |
Why?
|
| Cell Membrane Permeability | 5 | 2002 | 121 | 0.130 |
Why?
|
| Heart Rate | 1 | 2020 | 534 | 0.130 |
Why?
|
| Ion Transport | 1 | 2017 | 86 | 0.130 |
Why?
|
| Protein Stability | 2 | 2014 | 105 | 0.130 |
Why?
|
| NADPH Oxidase 2 | 1 | 2017 | 23 | 0.130 |
Why?
|
| Genes | 1 | 1997 | 256 | 0.130 |
Why?
|
| Actins | 1 | 2020 | 480 | 0.130 |
Why?
|
| Liver | 6 | 1993 | 1231 | 0.120 |
Why?
|
| Proteolysis | 2 | 2014 | 129 | 0.120 |
Why?
|
| Signal Transduction | 6 | 2019 | 3620 | 0.120 |
Why?
|
| Myometrium | 2 | 1996 | 62 | 0.120 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2016 | 20 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 66 | 0.120 |
Why?
|
| Peptides | 3 | 2009 | 669 | 0.120 |
Why?
|
| Neuroblastoma | 7 | 2004 | 409 | 0.120 |
Why?
|
| Pregnancy | 5 | 2018 | 3244 | 0.120 |
Why?
|
| Scattering, Radiation | 1 | 2016 | 122 | 0.120 |
Why?
|
| Models, Molecular | 2 | 2011 | 1391 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 169 | 0.120 |
Why?
|
| DNA, Complementary | 6 | 2007 | 380 | 0.120 |
Why?
|
| Ubiquitins | 1 | 1995 | 36 | 0.120 |
Why?
|
| Mitochondria | 1 | 2020 | 650 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 2555 | 0.110 |
Why?
|
| Tissue Distribution | 9 | 2000 | 290 | 0.110 |
Why?
|
| Cricetinae | 5 | 1996 | 533 | 0.110 |
Why?
|
| Pedigree | 4 | 2012 | 980 | 0.110 |
Why?
|
| Adult | 7 | 2025 | 29539 | 0.110 |
Why?
|
| Protein Conformation | 3 | 2011 | 923 | 0.110 |
Why?
|
| Photomicrography | 1 | 2014 | 7 | 0.110 |
Why?
|
| Genes, Dominant | 4 | 2012 | 111 | 0.110 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2012 | 82 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2014 | 80 | 0.100 |
Why?
|
| Molecular Weight | 7 | 1999 | 280 | 0.100 |
Why?
|
| Transgenes | 1 | 2014 | 173 | 0.100 |
Why?
|
| Muscle, Smooth | 2 | 1992 | 299 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2014 | 70 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2014 | 133 | 0.100 |
Why?
|
| Microscopy, Confocal | 5 | 2007 | 285 | 0.100 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 281 | 0.100 |
Why?
|
| Mandible | 1 | 1994 | 128 | 0.100 |
Why?
|
| Blotting, Western | 6 | 2004 | 780 | 0.100 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2020 | 115 | 0.100 |
Why?
|
| Fetal Heart | 1 | 1992 | 14 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2000 | 238 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 98 | 0.090 |
Why?
|
| Immunochemistry | 1 | 2012 | 18 | 0.090 |
Why?
|
| Osteogenesis | 1 | 1994 | 279 | 0.090 |
Why?
|
| Extracellular Space | 2 | 2011 | 84 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2007 | 679 | 0.090 |
Why?
|
| In Vitro Techniques | 9 | 2012 | 945 | 0.090 |
Why?
|
| Dogs | 9 | 1998 | 639 | 0.090 |
Why?
|
| Binding Sites | 5 | 2011 | 1159 | 0.090 |
Why?
|
| Heart | 7 | 2004 | 527 | 0.090 |
Why?
|
| Cytosol | 1 | 2012 | 193 | 0.090 |
Why?
|
| Stomach | 1 | 1992 | 110 | 0.090 |
Why?
|
| Time Factors | 9 | 2001 | 5567 | 0.090 |
Why?
|
| Permeability | 1 | 2011 | 145 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2011 | 112 | 0.090 |
Why?
|
| Hydrogen Bonding | 1 | 2011 | 160 | 0.090 |
Why?
|
| Skin | 1 | 1995 | 591 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 79 | 0.080 |
Why?
|
| Retina | 2 | 2007 | 221 | 0.080 |
Why?
|
| Phenotype | 8 | 2018 | 2638 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 1 | 2011 | 53 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2007 | 264 | 0.080 |
Why?
|
| 5' Untranslated Regions | 2 | 2001 | 52 | 0.080 |
Why?
|
| Galactosidases | 1 | 1990 | 13 | 0.080 |
Why?
|
| alpha-Galactosidase | 1 | 1990 | 5 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2000 | 157 | 0.080 |
Why?
|
| Fabry Disease | 1 | 1990 | 7 | 0.080 |
Why?
|
| 3' Untranslated Regions | 2 | 2001 | 102 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 802 | 0.080 |
Why?
|
| Young Adult | 2 | 2020 | 7507 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 396 | 0.080 |
Why?
|
| Aorta | 3 | 2001 | 275 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 1991 | 319 | 0.080 |
Why?
|
| Blood Vessels | 1 | 1990 | 92 | 0.080 |
Why?
|
| Cell Survival | 2 | 2007 | 1014 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1995 | 0.080 |
Why?
|
| Peptide Fragments | 4 | 2000 | 480 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2009 | 118 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 177 | 0.070 |
Why?
|
| Protein Multimerization | 3 | 2012 | 194 | 0.070 |
Why?
|
| In Situ Hybridization | 4 | 2004 | 306 | 0.070 |
Why?
|
| Islets of Langerhans | 2 | 1993 | 568 | 0.070 |
Why?
|
| Alanine | 1 | 2008 | 82 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1790 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 1998 | 101 | 0.070 |
Why?
|
| Family | 1 | 2009 | 327 | 0.070 |
Why?
|
| Arteries | 3 | 2000 | 171 | 0.070 |
Why?
|
| Coloring Agents | 2 | 2002 | 70 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 106 | 0.060 |
Why?
|
| Lung | 1 | 2014 | 1407 | 0.060 |
Why?
|
| Leupeptins | 2 | 1998 | 21 | 0.060 |
Why?
|
| Microinjections | 4 | 1998 | 67 | 0.060 |
Why?
|
| Macrophages | 1 | 1991 | 643 | 0.060 |
Why?
|
| Propidium | 1 | 2007 | 6 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 27 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2007 | 20 | 0.060 |
Why?
|
| Caspase 8 | 1 | 2007 | 32 | 0.060 |
Why?
|
| Osteoblasts | 3 | 1998 | 97 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2007 | 34 | 0.060 |
Why?
|
| Restriction Mapping | 3 | 1997 | 119 | 0.060 |
Why?
|
| Protein Binding | 2 | 2008 | 1554 | 0.060 |
Why?
|
| Genetic Engineering | 1 | 2007 | 102 | 0.060 |
Why?
|
| Solubility | 1 | 2007 | 187 | 0.060 |
Why?
|
| Middle Aged | 4 | 2025 | 29428 | 0.060 |
Why?
|
| Chromatography, Affinity | 3 | 2002 | 73 | 0.060 |
Why?
|
| Dacarbazine | 1 | 2026 | 104 | 0.060 |
Why?
|
| Transcription, Genetic | 4 | 2004 | 1133 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 889 | 0.060 |
Why?
|
| Biomarkers | 2 | 2025 | 2020 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2026 | 191 | 0.060 |
Why?
|
| Muscles | 3 | 1980 | 179 | 0.050 |
Why?
|
| MyoD Protein | 1 | 2004 | 16 | 0.050 |
Why?
|
| Rabbits | 3 | 2012 | 581 | 0.050 |
Why?
|
| Zebrafish | 2 | 1998 | 353 | 0.050 |
Why?
|
| Anisotropy | 2 | 1995 | 61 | 0.050 |
Why?
|
| Cell Line, Transformed | 3 | 1994 | 153 | 0.050 |
Why?
|
| Erythrocyte Membrane | 3 | 1982 | 61 | 0.050 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2004 | 2 | 0.050 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2004 | 28 | 0.050 |
Why?
|
| Polyamines | 1 | 2004 | 38 | 0.050 |
Why?
|
| Species Specificity | 4 | 1996 | 690 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2004 | 89 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 96 | 0.050 |
Why?
|
| Organ Specificity | 5 | 1998 | 287 | 0.050 |
Why?
|
| Clone Cells | 1 | 2004 | 220 | 0.050 |
Why?
|
| Aged | 2 | 2014 | 21758 | 0.050 |
Why?
|
| Lactose | 2 | 1982 | 26 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 193 | 0.050 |
Why?
|
| Structure-Activity Relationship | 4 | 2012 | 425 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2004 | 136 | 0.050 |
Why?
|
| Erythrocytes | 3 | 1982 | 242 | 0.050 |
Why?
|
| Anthraquinones | 1 | 2023 | 9 | 0.050 |
Why?
|
| Gestational Age | 1 | 2004 | 340 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2004 | 1717 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2000 | 1255 | 0.050 |
Why?
|
| Gene Library | 3 | 1993 | 125 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 7389 | 0.050 |
Why?
|
| Brefeldin A | 2 | 2005 | 10 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1604 | 0.050 |
Why?
|
| Isoelectric Focusing | 2 | 1995 | 28 | 0.050 |
Why?
|
| DNA Primers | 3 | 2007 | 530 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 126 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 108 | 0.050 |
Why?
|
| Genetic Linkage | 2 | 2006 | 613 | 0.050 |
Why?
|
| Heterozygote | 3 | 2018 | 390 | 0.050 |
Why?
|
| Lactates | 2 | 1982 | 34 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2026 | 665 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2007 | 304 | 0.040 |
Why?
|
| Veins | 2 | 2000 | 87 | 0.040 |
Why?
|
| Epithelium | 4 | 1994 | 316 | 0.040 |
Why?
|
| Serine | 1 | 2022 | 106 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2006 | 107 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2001 | 93 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2004 | 1147 | 0.040 |
Why?
|
| Sinoatrial Node | 2 | 1998 | 13 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 32 | 0.040 |
Why?
|
| Sucrose | 1 | 2001 | 63 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2001 | 94 | 0.040 |
Why?
|
| Antibody Specificity | 3 | 1998 | 126 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2026 | 1394 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 1 | 2000 | 5 | 0.040 |
Why?
|
| Pineal Gland | 1 | 2000 | 16 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 642 | 0.040 |
Why?
|
| Receptors, Mitogen | 1 | 1980 | 2 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1995 | 450 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 1980 | 31 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2000 | 91 | 0.040 |
Why?
|
| Neural Conduction | 2 | 1998 | 72 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2019 | 15 | 0.040 |
Why?
|
| Introns | 1 | 2001 | 301 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 92 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 165 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2019 | 84 | 0.040 |
Why?
|
| Immunoassay | 1 | 2000 | 102 | 0.040 |
Why?
|
| RNA, Complementary | 2 | 1999 | 8 | 0.040 |
Why?
|
| Capillaries | 1 | 2000 | 86 | 0.040 |
Why?
|
| Protozoan Proteins | 1 | 1980 | 76 | 0.040 |
Why?
|
| Mesocricetus | 2 | 1996 | 103 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 142 | 0.040 |
Why?
|
| Glycolates | 2 | 1982 | 2 | 0.040 |
Why?
|
| Uterus | 2 | 1991 | 232 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 2 | 1982 | 9 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2000 | 121 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 272 | 0.040 |
Why?
|
| Endocardial Cushion Defects | 1 | 1999 | 3 | 0.040 |
Why?
|
| Fluoresceins | 5 | 1998 | 43 | 0.040 |
Why?
|
| Rats, Inbred Strains | 4 | 1991 | 300 | 0.040 |
Why?
|
| Insulin | 2 | 1997 | 1225 | 0.040 |
Why?
|
| Vena Cava, Superior | 1 | 1999 | 54 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2009 | 720 | 0.040 |
Why?
|
| Ammonium Chloride | 1 | 1998 | 22 | 0.030 |
Why?
|
| Chloroquine | 1 | 1998 | 15 | 0.030 |
Why?
|
| Leucine | 1 | 1998 | 57 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1999 | 43 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1998 | 52 | 0.030 |
Why?
|
| Angiotensin II | 1 | 1998 | 98 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 2018 | 5 | 0.030 |
Why?
|
| RNA | 5 | 1996 | 595 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 548 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 55 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1998 | 114 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 1998 | 73 | 0.030 |
Why?
|
| Monensin | 1 | 1997 | 16 | 0.030 |
Why?
|
| Dinoprostone | 1 | 1998 | 80 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 1997 | 28 | 0.030 |
Why?
|
| Oxytocics | 1 | 1998 | 26 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 1995 | 831 | 0.030 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2017 | 19 | 0.030 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2017 | 33 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2018 | 62 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1998 | 119 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 162 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 89 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 1999 | 118 | 0.030 |
Why?
|
| Homeostasis | 1 | 2000 | 474 | 0.030 |
Why?
|
| Genome | 1 | 2000 | 417 | 0.030 |
Why?
|
| Crystallization | 1 | 2018 | 219 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 84 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2017 | 118 | 0.030 |
Why?
|
| Bucladesine | 1 | 1996 | 12 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 1998 | 233 | 0.030 |
Why?
|
| Cell Count | 1 | 1997 | 195 | 0.030 |
Why?
|
| Notochord | 1 | 1996 | 22 | 0.030 |
Why?
|
| Sodium | 1 | 2018 | 330 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1980 | 667 | 0.030 |
Why?
|
| Cell Division | 2 | 1997 | 689 | 0.030 |
Why?
|
| Antimetabolites | 1 | 1995 | 22 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1995 | 35 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 4 | 1994 | 1416 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 660 | 0.030 |
Why?
|
| CHO Cells | 1 | 1995 | 188 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1836 | 0.030 |
Why?
|
| RNA Probes | 2 | 1995 | 16 | 0.030 |
Why?
|
| Prodrugs | 1 | 1995 | 53 | 0.030 |
Why?
|
| Simplexvirus | 1 | 1995 | 66 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1980 | 834 | 0.030 |
Why?
|
| Arterioles | 1 | 1995 | 25 | 0.030 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1995 | 11 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 1995 | 393 | 0.030 |
Why?
|
| Fetal Proteins | 1 | 1994 | 19 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 2014 | 5 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2014 | 25 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1991 | 195 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 38 | 0.030 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2014 | 18 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1994 | 115 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 60 | 0.030 |
Why?
|
| Infant | 4 | 2012 | 3328 | 0.030 |
Why?
|
| Cornea | 1 | 1994 | 55 | 0.030 |
Why?
|
| Fibroblasts | 2 | 1995 | 767 | 0.030 |
Why?
|
| Benzodioxoles | 1 | 2014 | 15 | 0.030 |
Why?
|
| Endocrine Glands | 1 | 1993 | 13 | 0.030 |
Why?
|
| Exocrine Glands | 1 | 1993 | 2 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 911 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Death, Sudden | 1 | 2014 | 43 | 0.030 |
Why?
|
| Echocardiography | 2 | 2014 | 783 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1999 | 508 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 256 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 164 | 0.020 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2013 | 4 | 0.020 |
Why?
|
| Hydrazones | 1 | 2013 | 7 | 0.020 |
Why?
|
| Heptanol | 1 | 1993 | 1 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1993 | 35 | 0.020 |
Why?
|
| Alcohols | 1 | 1993 | 14 | 0.020 |
Why?
|
| Purkinje Fibers | 1 | 1993 | 28 | 0.020 |
Why?
|
| Sheep | 3 | 2002 | 204 | 0.020 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1993 | 9 | 0.020 |
Why?
|
| Reference Values | 3 | 2000 | 608 | 0.020 |
Why?
|
| Anisomycin | 1 | 2012 | 9 | 0.020 |
Why?
|
| Anthracenes | 1 | 2012 | 13 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 66 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 1993 | 52 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2013 | 233 | 0.020 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2012 | 23 | 0.020 |
Why?
|
| Heart Diseases | 1 | 1995 | 268 | 0.020 |
Why?
|
| Body Water | 1 | 2012 | 34 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 313 | 0.020 |
Why?
|
| Extremities | 1 | 1994 | 173 | 0.020 |
Why?
|
| Cataract Extraction | 1 | 2012 | 31 | 0.020 |
Why?
|
| Quinazolines | 1 | 2014 | 221 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 564 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1994 | 207 | 0.020 |
Why?
|
| Electrocardiography | 3 | 2000 | 527 | 0.020 |
Why?
|
| Buffers | 1 | 2011 | 24 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1993 | 418 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1992 | 353 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 1991 | 58 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1991 | 220 | 0.020 |
Why?
|
| Glyburide | 1 | 1991 | 33 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 1994 | 315 | 0.020 |
Why?
|
| Genes, src | 1 | 1990 | 5 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2037 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 525 | 0.020 |
Why?
|
| Spleen | 2 | 1990 | 375 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 36 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 51 | 0.020 |
Why?
|
| Hymecromone | 1 | 1990 | 3 | 0.020 |
Why?
|
| Chemistry | 1 | 1990 | 46 | 0.020 |
Why?
|
| Glycosides | 1 | 1990 | 12 | 0.020 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1990 | 6 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1990 | 65 | 0.020 |
Why?
|
| Rhodamines | 1 | 1990 | 20 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 1994 | 2529 | 0.020 |
Why?
|
| Dextrans | 1 | 1990 | 77 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2011 | 148 | 0.020 |
Why?
|
| Aging | 2 | 2012 | 770 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 3212 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 186 | 0.020 |
Why?
|
| Ecdysterone | 1 | 2009 | 2 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1989 | 20 | 0.020 |
Why?
|
| Granulosa Cells | 1 | 1989 | 32 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 3 | 1994 | 66 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 814 | 0.020 |
Why?
|
| Electron Microscope Tomography | 1 | 2008 | 25 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 196 | 0.020 |
Why?
|
| Swine | 1 | 1990 | 592 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 122 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 201 | 0.020 |
Why?
|
| Plasmids | 2 | 2000 | 275 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1990 | 461 | 0.020 |
Why?
|
| Calbindins | 1 | 2007 | 16 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 28 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2007 | 25 | 0.020 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2007 | 19 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 257 | 0.020 |
Why?
|
| Protein Kinase C-alpha | 1 | 2007 | 29 | 0.020 |
Why?
|
| Immune Sera | 2 | 1990 | 48 | 0.010 |
Why?
|
| Ovary | 1 | 1987 | 260 | 0.010 |
Why?
|
| DNA Probes | 3 | 1991 | 66 | 0.010 |
Why?
|
| Chromosome Segregation | 1 | 2006 | 35 | 0.010 |
Why?
|
| Arthritis, Juvenile | 1 | 1986 | 35 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 150 | 0.010 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2004 | 14 | 0.010 |
Why?
|
| Polyelectrolytes | 1 | 2004 | 7 | 0.010 |
Why?
|
| GATA4 Transcription Factor | 1 | 2004 | 21 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 74 | 0.010 |
Why?
|
| Isoelectric Point | 2 | 1982 | 12 | 0.010 |
Why?
|
| Ventricular Function | 1 | 2004 | 41 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 163 | 0.010 |
Why?
|
| Monocytes | 1 | 1986 | 219 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1986 | 270 | 0.010 |
Why?
|
| Mathematics | 2 | 1994 | 176 | 0.010 |
Why?
|
| Brain | 2 | 1989 | 2430 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2004 | 123 | 0.010 |
Why?
|
| Second Messenger Systems | 2 | 1995 | 39 | 0.010 |
Why?
|
| Haplotypes | 1 | 2006 | 656 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 4823 | 0.010 |
Why?
|
| Probability | 2 | 1994 | 356 | 0.010 |
Why?
|
| T-Box Domain Proteins | 1 | 2004 | 139 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1989 | 488 | 0.010 |
Why?
|
| Lysine | 1 | 2004 | 181 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 1962 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1982 | 139 | 0.010 |
Why?
|
| Cell Aggregation | 2 | 1998 | 37 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 566 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 2000 | 25 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1950 | 0.010 |
Why?
|
| Hemagglutination | 1 | 1980 | 7 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1980 | 23 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1980 | 40 | 0.010 |
Why?
|
| Discoidins | 1 | 1980 | 2 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 303 | 0.010 |
Why?
|
| Trachea | 1 | 2000 | 249 | 0.010 |
Why?
|
| Astrocytes | 1 | 2000 | 142 | 0.010 |
Why?
|
| Tetrathionic Acid | 1 | 1978 | 1 | 0.010 |
Why?
|
| Thiosulfates | 1 | 1978 | 3 | 0.010 |
Why?
|
| Injections | 1 | 1999 | 131 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1255 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 80 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 1999 | 125 | 0.010 |
Why?
|
| Biophysics | 1 | 1999 | 154 | 0.010 |
Why?
|
| Agglutinins | 1 | 1978 | 4 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1978 | 22 | 0.010 |
Why?
|
| Chloromercuribenzoates | 1 | 1978 | 4 | 0.010 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 1978 | 6 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1998 | 32 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1999 | 161 | 0.010 |
Why?
|
| Colforsin | 1 | 1998 | 68 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1978 | 102 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1998 | 57 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1980 | 822 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1999 | 289 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1997 | 20 | 0.010 |
Why?
|
| Receptors, Purinergic | 1 | 1997 | 7 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1997 | 56 | 0.010 |
Why?
|
| Trypsin | 1 | 1997 | 92 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1998 | 277 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1997 | 120 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 271 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1997 | 116 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 118 | 0.010 |
Why?
|
| Temperature | 1 | 1978 | 442 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1995 | 18 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 36 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1998 | 743 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1995 | 30 | 0.010 |
Why?
|
| Diffusion | 1 | 1995 | 95 | 0.010 |
Why?
|
| Chromones | 1 | 1995 | 31 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 2002 | 0.010 |
Why?
|
| Surface Properties | 1 | 1995 | 129 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 1995 | 88 | 0.010 |
Why?
|
| Liposomes | 1 | 1995 | 104 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1996 | 204 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 370 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1995 | 426 | 0.010 |
Why?
|
| Bundle of His | 1 | 1994 | 63 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1993 | 20 | 0.010 |
Why?
|
| Lacrimal Apparatus | 1 | 1993 | 11 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1995 | 518 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1993 | 72 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 18 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1993 | 77 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1993 | 117 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1993 | 129 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1992 | 15 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 1061 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1993 | 157 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1993 | 269 | 0.010 |
Why?
|
| Morula | 1 | 1991 | 3 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1994 | 508 | 0.010 |
Why?
|
| Pancreas | 1 | 1993 | 269 | 0.010 |
Why?
|
| Blastocyst | 1 | 1991 | 34 | 0.010 |
Why?
|
| Estrus | 1 | 1991 | 38 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1991 | 13 | 0.010 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 1991 | 12 | 0.010 |
Why?
|
| Decidua | 1 | 1991 | 22 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1999 | 4025 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1993 | 318 | 0.010 |
Why?
|
| Zygote | 1 | 1991 | 45 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1991 | 63 | 0.010 |
Why?
|
| Tyrosine | 1 | 1990 | 135 | 0.010 |
Why?
|
| Biological Transport, Active | 2 | 1982 | 98 | 0.010 |
Why?
|
| Arvicolinae | 1 | 1990 | 3 | 0.000 |
Why?
|
| Prostate | 1 | 1993 | 434 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1989 | 161 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1989 | 1110 | 0.000 |
Why?
|
| Calcium Radioisotopes | 1 | 1986 | 4 | 0.000 |
Why?
|
| Aurothioglucose | 1 | 1986 | 2 | 0.000 |
Why?
|
| Penicillamine | 1 | 1986 | 12 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1986 | 215 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1986 | 117 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1982 | 95 | 0.000 |
Why?
|
| Mitogens | 1 | 1980 | 58 | 0.000 |
Why?
|
| Sulfates | 1 | 1978 | 38 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1980 | 830 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1978 | 34 | 0.000 |
Why?
|
| X-Rays | 1 | 1978 | 139 | 0.000 |
Why?
|
| Chlorides | 1 | 1978 | 102 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1978 | 327 | 0.000 |
Why?
|
| Antigens | 1 | 1978 | 225 | 0.000 |
Why?
|